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Abstract: Information and Communication Technologies – as analyzed in this 
book - could allow a radical change in the way healthcare services are delivered 
to the citizens and could represent an effective tool to cope with the today’s 
healthcare challenges.  
In this chapter we introduce two European research projects where large part of 
the concepts addressed in this book are applied; they are the MICHELANGELO 
project of the 7th  Framework Program and CHIRON of the ARTEMIS JU Pro-
gram.   
The CHIRON project (Cyclic and person-centric health management: Integrated 
approach for home, mobile and clinical environments) focuses on prevention i.e. 
on a move away from ‘health care’ towards ‘health management’, from ‘how to 
treat patients’ to ‘how to keep people healthy’, from a “reactive care” to a “pro-
active care”. CHIRON designed a system’s architecture making possible a “con-
tinuum of care” i.e. an integrated health management approach in which health is 
patient-centric at home, in the hospital and in nomadic environments.  Care is 
moved from the hospital to the home and the healthcare staff is enlarged by add-
ing informal carers to the medical professionals and by motivating and empower-
ing the patient himself to manage his own health.  Moreover the CHIRON system 
builds a personalized risk assessment of the patient by integrating personal infor-
mation, data gathered at home and in a mobile environment through an innovative 
set of wearable sensors and data available at the hospital including outcomes of 
image-based tests. The expected results are a reduction of the healthcare costs 
and a better quality of care. 
MICHELANGELO addresses a specific category of patients i.e. the autistic chil-
dren; the aim is to use ICT to promote and facilitate the assessment of autism 
within the home setting, away from the traditional clinical environments and to 
provide personalized “home-based” intervention strategies. This is achieved 
through the provision of cost-effective, patient-centric home-based intervention 
remotely controlled by the therapist (remote rehabilitation).  The proposed meth-
od aims at enhancing the effectiveness of the treatment through its “intensive-
ness” and “personalization” matching the individual characteristics of autistic 
children and the involvement of the parents in their “natural” home environment 
in the role of “co-therapists”. 
Both projects offer interesting inputs on how Information and Communication 
Technology could help in “revolutionizing” healthcare. It is worthwhile to high-
light that both projects keep the doctors at the core of the healthcare process and 
in both of them technology is not replacing the experience and the competences of 
the medical professionals and is not removing the needed physical contact be-
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tween them and the patients but it supports the doctors in executing their tasks in 
a more effective and better way.  
 
This chapter is split into two parts: in the first we will introduce the two projects 
mainly from a strategic perspective in line with the current efforts towards “radi-
cal changes” needed to cope with the heavy challenges the healthcare system is 
facing. 
The second part gives a technological insight of the CHIRON project and shows 
how this project is deploying several of the concepts analyzed in the previous 
chapters of this book. 
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Introduction 
As an effective response to the current challenges in healthcare we need a radical 
change of the way healthcare services are delivered to the citizens; we need to 
move care from the hospital to home to take benefit from the availability of infor-
mal caregivers and enable a more affordable healthcare service by reducing the 
need of hospitalization. This will translate into early intervention when the eco-
nomic impact of the disease is still low. 
The previous chapters of this book have shown how advanced ICT-based solu-
tions applied to medicine (what we call e-health) could contribute to the achieve-
ment of the ultimate goal i.e. a better quality of care at more affordable costs.  
In this chapter we analyze two European research projects representing interest-
ing case studies, the CHIRON project of the ARTEMIS JU Program, and the 
MICHELANGELO project of the FP7-ICT - both projects emphasize the active 
role of patients and citizens, promote a person-centred healthcare with the patient 
at the core of the overall process and recognize the individual, specific characteris-
tics of each patient.  
CHIRON addresses the entire healthcare chain and proposes a new approach and 
a reference architecture fostering a continuum of care; the MICHELANGELO pro-
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ject focuses on the treatment of children suffering from Autism Spectrum Disor-
ders and introduces ICT and cost-effective, patient-centric home-based interven-
tion remotely controlled by the doctors to promote the assessment and the therapy 
of autism within the home setting, away from the traditional clinical environments.  
The overall chapter is divided in two parts. In the first part the strategic views of 
the CHIRON and MICHELANGELO project are described to give the reader a 
flavor of the possible broad spectrum of applications and how a remote healthcare 
system could be applied in practice within that spectrum. The second part is more 
technology orientated. Here we restrict ourselves within the detailed description of 
the CHIRON system only because of the fact that it represents an excellent exam-
ple of an advanced remote healthcare system developed by the joint effort of In-
dustry, Academia and Research Institutes. In this case we start from the basic func-
tional requirements of the system and show in step-by-step fashion how the 
complete end-to-end system is developed. Without loss of generality, such an ap-
proach could be followed for developing any applications orientated remote 
healthcare system.   
  
 
 
10.1   The CHIRON project 
Healthcare is facing demographic and socio-economic challenges: from an ever 
ageing population suffering from chronic diseases and various handicaps to the 
need for affordable “global” healthcare provided by fewer and fewer professionals 
and medical infrastructures for critical, often mobile, patients. 
Moreover medicine is confronted by the “age of globalization”: the movement 
of people all over the world along with societal and economic developments 
means that medical professionals have to deal with new diseases, new symptoms 
and new contextual factors relevant to the health of the citizens, such as changed 
environments, new nutritional habits and lifestyles. 
Healthcare – traditionally focused on institutional care and on curing diseases 
(diagnosis, treatment, rehabilitation) – needs to shift towards monitoring, risk as-
sessment and early detection to effectively manage chronic diseases and to reduce 
– at least – complications. We need a shift from “health care” (how to treat pa-
tients) to “health management” (how to keep people healthy). 
CHIRON (Cyclic and person-centric health management: Integrated approach 
for home, mobile and clinical environments) is a European research project of the 
ARTEMIS JU Program and is addressing these issues; it has received funding 
from the ARTEMIS Joint Undertaking under grant agreement no 100228 and from 
the National Governments participating to the project. 
27 Organizations from eight European member states and representing the in-
dustry (large companies and SMEs), the research and the academic communities 
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and medical institutions are involved1. Having started in March 2010, the project 
has a term of 45 months and a budget of 18 million Euro.  
The project addresses one of the today’s societal challenges i.e. “effective and 
affordable healthcare and wellbeing”. CHIRON combines state-of-the art technol-
ogies and innovative solutions into an integrated framework of embedded systems 
for effective and person-centred health management throughout the complete 
healthcare cycle, from primary prevention (person still healthy) to secondary 
prevention (initial symptoms or discomfort) and tertiary prevention (disease 
diagnosis, treatment and rehabilitation) in various domains: at home, in nomadic 
environments and in clinical settings.  
Fig. 10.1 – CHIRON addresses the complete healthcare cycle 
 
It applies several of the approaches and techniques discussed in the previous 
sections of this book. 
In currently applied healthcare practice, a disease is commonly discovered after 
symptoms have emerged. Only then, people become patients and apply for medi-
cal care, a diagnosis is made and a treatment is proposed and initiated.  CHIRON 
fosters a change in this approach i.e. a shift towards an earlier diagnosis based on 
the risk assessment of the still healthy person. 
 
                                                            
1 The following Organizations are participating at the CHIRON project: FIMI Srl, Univer‐
sities of Bologna, Genova, Roma, Trieste, CNR, I+ Srl, ITS, SELEX ES, W‐LAB Srl from Ita‐
ly; ALMA, ATOS, CEIT, CIMNE, Ibermatica ,Tecnalia from Spain; Athena ISI and Intracom 
from  Greece;  BARCO  from  Belgium;  Philips  Healthcare  and  ZorgGermak  from  The 
Netherlands; University of Budapest  from Hungary;  Jozef  Stefan  Institute  and Mobili 
from Slovenia; Cardionetics , Southampton University Hospitals NHS Trust  and Univer‐
sity of Southampton from United Kingdom. 
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Fig.10.2 – From treatment of patients to early risk assessment and management 
of still healthy persons 
 
In CHIRON, detection and diagnosis are based on the analysis of heterogeneous 
medical data that originate from personal data of the patient, medical past 
knowledge, imaging systems, collection of vital sign data through sensors and 
handheld devices.  Medical doctors having remote access to the person’s health 
record are able to take a more proactive role in prevention of diseases. 
This is a significant innovation compared to the currently used approaches that 
are based on health-related parameters only, often monitored instantaneously and 
episodically (during clinical center visits). In addition CHIRON intends to explore 
the correlation across physiological, psycho-emotional and environmental parame-
ters. 
The CHIRON system involves modeling at different structural and functional 
scales, combining inputs from sensor data, medical imaging, clinical diagnoses, 
patient history and population-level statistical information. Continuous and close-
to-the patient remote monitoring of physiological and psycho-emotional state and 
trends are integrated and contextualized with environmental parameters, infor-
mation on patient activity and lifestyle related factors. Measurements provided by 
the sensors are incorporated into physiological models and fused with anatomical 
and functional information derived from MRI and 3D ultrasound data, from which 
organ-level models are built and updated. The CHIRON reference architecture en-
sures interoperability between heterogeneous devices and services, a reliable and 
secure patient data management and a seamless integration with the clinical work-
flow. 
A new way of looking at impending risk is constructed, based on simple 
measures obtained on a continuous basis with time-frame acquisitions, processing 
and relation with future events depending on the type of variable considered: heart 
rate, skin and ambient temperature and humidity, daily weight, water and urine 
variations and in house movements (1). 
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It is worthwhile to notice that such a correlation model does not exist in practice; 
presently diagnosis of a disease depends largely on the experience of the individu-
al doctors. The typical models for diseases only predict mortality or morbidity in 
long term but never identify “when actually” the person is at risk. 
10.1.1 The CHIRON concepts 
In the field of e-health CHIRON represents an interesting case study since it ap-
plies innovative approaches made possible by advanced ICT solutions of which 
some already addressed in this book. More specifically the CHIRON research 
work is based on three main concepts (2), (3): 
a. The realization of a “continuum of care” i.e., addressing in an integrated 
approach health management at home, in the hospital and in a nomadic en-
vironment.  
b. A “person-centred approach” where the needs of the citizens, the medical 
professionals and the whole community are at the core of the design and 
the uniqueness of each user is fully recognized (“personalized healthcare”) 
including the use of proactive solutions anticipating the needs of people, 
adapting themselves to context and taking the required actions and thus en-
riching quality of life and fostering independence; 
c. A knowledge-based system integrating past and current data of each patient 
together with statistical data related to the whole community in a large and 
distributed repository (in CHIRON called Virtual Data Repository) and 
promotes a move towards prevention and early risk assessment. 
 
Fig. 10.3 – The basic concepts of the CHIRON approach 
 
 
A.  Care at home and everywhere (“continuum of care”) 
 A continuous multi-parametric monitoring of physiological and psycho-
emotional state, environmental parameters, patient activity and lifestyle related 
factors has been realized and the best compromise between unobtrusiveness and 
accuracy of the gathered data was pursued in designing it.  
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Measurements provided by the close-to-the patient remote monitoring are incor-
porated into physiological models and fused with anatomical and functional in-
formation derived from MRI and 3D ultrasound data, from which organ-level 
models are built and updated. 
All these data - integrated with those available in the Hospital Information Sys-
tem - contribute to the building of an evolving Patient Health Profile and to the 
definition of a personalized and constantly updated risk assessment model (identi-
fied in CHIRON as Alter Ego).  
In the CHIRON architecture, high emphasis is given to the seamless integration 
of the personal health platform with the clinical workflow and the integration of 
the personal and medical data gathered in a “non-clinical setting” into the elec-
tronic health record of the patient. Adherences to standards with regard to the ex-
change of the medical information (HL7 v.3) as well as reliable and secure patient 
data management are key issues.  Semantic interoperability is realized. 
 
B. A person-centric healthcare management 
CHIRON provides personalization in the delivery of the healthcare services. 
The “one size fits all” paradigm will no longer apply, especially when it comes to 
medicine. Personalization will also feature in a coaching system to help the pa-
tient to reduce immediate risk and improve long term recovery. Patients are em-
powered and motivated to self-manage their wellbeing. This person-centred ap-
proach puts the needs of the citizens, the medical professionals and the whole 
community at the core of the CHIRON design.  Health is considered a value the 
single person and the whole community have to build and preserve. 
The user profile represents an evolving model of the relevant aspects related to 
the health of a user and provides a continuously up-to-date risk assessment of his 
health status.  
 
C. A knowledge-based medicine  - Support to the doctors  
To make a diagnosis, to define the most suited treatment for the patient, the phy-
sician needs to make use of a massive quantity of data, aggregated from different 
large data sets, interpreted and integrated with community related statistical data 
and past knowledge.  Moreover he needs to take timely decisions. 
All these data represent the outputs of multiple and heterogeneous devices and 
subsystems ubiquitously distributed: physiological signs and activity information 
are gathered through unobtrusive on-body sensors and are contextualized with en-
vironmental parameters measured by discrete devices; results of lab analyses in-
cluding image-based examinations are available in the information systems and 
PACS systems of the clinical centres and hospitals, epidemiological / statistical 
datasets and past knowledge are dispersed everywhere all across the world and 
sometime organized and stored in various repositories. In CHIRON all of them – 
integrated in the Virtual Data Repository (VDR) - provide medical professionals 
with an effective support for early diagnosis and personalized treatment planning.  
A critical aspect CHIRON addresses, is the effectiveness and the intuitiveness of 
the feedback provided to the medical professionals, avoiding the risk of overload-
ing the doctors with a plethora of data. CHIRON interprets and translated those 
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data into features. An ontological approach is used to retrieve information from 
multiple distributed content repositories and present it in a structured and aggre-
gated manner giving the doctor an easy and powerful tool for immediate under-
standing of the status of the patient. 
Fig.10.4 – Intuitive and effective feedback to the doctor 
 
We are aware that technology cannot replace the experience of the medical doc-
tors but can support them in taking the most appropriate and timely decision. In 
CHIRON the doctor remains the protagonist of the healthcare process and the only 
owner of the clinical decision.  
 
 
 
10.1.2 The CHIRON architecture 
 
In the CHIRON architecture all the devices /subsystems generating, interpreting 
and storing data are embedded modules of an overall complex system; each of 
them has the computing and memory capabilities to execute a specific task for 
which the outputs of other sub-systems are needed.  The task of each of these em-
bedded blocks could be very simple such as processing the raw data, removing ar-
tefacts and extracting features. Tasks may also be complex such as that of a medi-
cal image acquisition system or an image-guided surgical system.  
In contrast to the typical architectures, keeping in mind the energy constraint of 
a sensor node, specialized low-complexity algorithms were developed for on-
board signal denoising, artifact removal, intelligent classifier and feature extractor 
for each of the electrophysiology sensors without compromising the medically 
trustworthiness quality of the captured signals were realized.  
In this network of embedded systems Internet provides the communication 
infrastructure for the exchange of information among them and the weaknesses of 
Internet in terms of quality, reliability and real time interchange of the information 
are compensated by a higher autonomy and robustness of each of the modules of 
the system.  Each block is capable of operating independably even in the presence 
of network degradation or temporary failure and is able of  executing a minimal, 
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essential task autonomously (e.g. the prompt warning of the patient if a vital sign 
is above the allowed threshold or the activation of an emergency call in the case of 
a critical event).  
In this regard, the CHIRON project realizes the vision driving the European 
ARTEMIS JU Program  i.e. a world in which smart “objects” have “a presence in 
cyber space, exploit the digital information and services around them, communi-
cate with each other, with the environment and with people, and manage their re-
sources autonomously” (4). CHIRON intends to contribute to the realization of 
this vision in a so important and complex domain such as the healthcare one. Be-
ing the citizen and his quality of life at the core of the healthcare model proposed 
by the project, the CHIRON system – even if specifically designed for healthcare 
– interoperates across many application domains. CHIRON will use a middleware 
which will allow not only to achieve interoperability between heterogeneous de-
vices and services, exchange of multisource information among the overall 
healthcare cycle but also will enable a multi-domain compatibility. In a complex 
and global society, primary needs such as the health and the wellbeing of the citi-
zens ask for the harmonized and synergic contribution of various actors. 
 
10.1.3 Technological challenge and innovation in CHIRON 
The project promises to progress beyond state-of-the art in several disciplines 
(5) such as healthcare architecture, sensor  nodes with enhanced capabilities, new 
methods and algorithms for the measurement of physiological parameters, ad-
vanced solutions for the analysis and the visualization of medical images. 
The technological challenges of this full integration of a Personal Health System 
into the conventional hospital-based Healthcare System are in the realization of 
the best synergy among conflicting requirements such as:  
 data gathering and data processing in resource-constrained systems (the 
wireless mobile sensors network),  
 non-invasiveness of the monitoring combined with accuracy of the 
measured data,  
 continuous monitoring vs. the acceptance of the solution by the pa-
tients,  
 automation or minimal human intervention vs. the reliability of the 
feedback,  
 availability of a massive quantity of data vs. the easy and fast interpre-
tation of these data by the medical professional,  
 privacy and security of data vs. easy and ubiquitous access to these data 
by authorized persons, etc. 
  
The advanced solution proposed by CHIRON represents a solid contribution to 
solve these issues. More specifically CHIRON developed: 
a. sensor nodes with enhanced capabilities (multi-parametric monitor-
ing, local processing, energy harvesting and power management), 
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b. innovative methods for the measurement of biological parameters 
(ECG, blood pressure with enhanced accuracy, serum potassium con-
centration in the blood), 
c. advanced solutions for the analysis and the visualization of medical 
images, 
d. a dynamic and personalized risk assessment model (Alter Ego), 
e. a distributed data storage approach (Patient’s Virtual Data Reposito-
ry) with enhanced data security and privacy provisions.   
In the current age of image-centred medicine the new advanced tools developed 
in the CHIRON project are expected to facilitate real time processing, computer-
aided detection and accurate visualization of medical image as well as to support 
doctors in making accurate diagnosis by reducing the risk of a “false negative” or 
the need for additional and costly examinations due to a “false positive”.  
 
10.1.4 Conclusions 
The CHIRON research project contributes in promoting a new way of delivering 
healthcare services and promotes a paradigm shift from diagnosis and treatment of 
patients based on symptoms to diagnosis of patients based on risk assessment of 
healthy persons. 
Moreover CHIRON intends to contribute to the uptake of a market still in its 
nascent phase, the e-health one, identified by the European Commission as a “lead 
market” where “innovative products / services / solutions have high growth poten-
tial, where EU industry can develop competitive advantage and where action by 
the public authorities to deal with regulatory obstacles is needed”.   
CHIRON contributes to bridge the gap between R&D and market readiness. 
The healthcare societal challenges will promote the creation of new and innova-
tive services / products and the solutions and the technological advances made in 
CHIRON will contribute to the uptake of applications such as medical imaging, 
personal healthcare (home and mobile monitoring), health management and 
coaching, wellbeing, clinical decision support systems and healthcare informatics. 
The move towards “global, open networks of multi-domain embedded systems” 
will lead to radical changes in the business processes, by asking for cross-
company collaborations.   
 
 
 
 
10.2   The MICHELANGELO project 
10.2.1 Background 
 
The MICHELANGELO project is co-financed by the European Commission 
(Framework Program 7 – Grant Agreement # 288241). It aims to use emerging 
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technologies to propose personalized home-based intervention strategies for chil-
dren with Autism Spectrum Disorders. MICHELANGELO brings together an in-
terdisciplinary team of eight partner organizations in Italy, Malta, United King-
dom and France and bridges academia, industry, research and clinical practice2 .  
In the diagnostic manual used to classify disabilities (the DSM-IV of the Ameri-
can Psychiatric Association, ‘Autistic Disorder’ (AD) is listed as a category under 
the heading of ‘Pervasive Developmental Disorders (PDP)’. It affects thought, 
perception and attention and social interaction and – rather than one disorder with 
a well-defined set of symptoms – it represents a broad spectrum of disorders that 
ranges from mild to severe (Autistic Spectrum Disorders – ASD). 
According to a recent study (6) the prevalence of Autism Spectrum Disorders 
(ASD) in the young population has increased in USA from the 0.6-0.7% of the 
previous 2003 estimate in excess of 1% (i.e. from 1 in every 150 children to 1 in 
every 91 children). A similar situation has been reported in Europe where the 
prevalence of autism in children increased from the 0.5-0.7% (7) to 1.16 % as re-
ported by Kuehn (8) and by several other studies. These trends have considerable 
social and economic impacts. The average lifetime costs for a person with autism 
were evaluated at approximately €5.7 million for people with low functioning au-
tism and €1.5 million for people with high functioning autism (9). 
Consolidated data on the prevalence of autism in Europe is lacking. Variability 
in reported data is often due to methodological factors; the result is that ‘there is 
no comprehensive or comparable data at EU level concerning the incidence or 
prevalence of this disease’ (report of the European Commission dated 2004). In 
reviewing various prevalence studies, Williams JG at al. found that 50 per cent of 
the variation among study estimates could be explained by factors such as age of 
the screened children, diagnostic criteria used, country, rural or urban location, 
etc. 
Equally, in Europe, the social and economic burden of ASD has not been ade-
quately recorded, as epidemiological figures are unreliable and inconsistent. In a 
recent report, the economic consequences of autism in the UK were calculated and 
the findings reveal that children with autism cost £2.7 billion (Euros 3.8 billion) 
annually, yet for adults the figure is £25 billion (Euros 36.2 billion) - over eight 
times as much.  
 It is well accepted in the scientific community the importance of an early diag-
nosis of autism and that prognosis is greatly improved if a child is placed into an 
early intensive and highly structured educational program by age of three years 
old. Early treatment is a crucial step to ameliorate some of the symptoms              
associated with autism and some investigators have reported that this is a critical 
developmental period in a child’s life during which brain’s plasticity is maximal 
and environmental influences can interfere with neural connections (10). Moreo-
                                                            
2 The following Organizations are participating to the MICHELANGELO Projects : 
FIMI S.r.l., Italian National Research Council (CNR), Fondazione SteIla Maris and + Srl  
(Italy); University of Southampton and University of Ulster (United Kingdom); Univer-
sity Pierre et Marie Curie, Paris (France); Across Limits Ltd. (Malta). 
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ver, researchers agree on the inadequacy of one single treatment approach for all 
the children with ASD due to the heterogeneity and the developmental nature of 
the disorder. Earlier identification of children with ASD and the development of      
personalized and evolving protocols for intervention could increase the effective-
ness of the treatment. Both these objectives could be achieved with the support of 
the technology as developed in the MICHELANGELO project. Moreover re-
searchers are starting to develop prosthetic technologies able to help children 
with autism by supplementing or replacing the natural capacities. Advances in key 
technology areas such as affective computing and wearable computing offer a lot 
of potential for computer-based prosthetic tools. 
 
10.2.2 The Michelangelo project: concepts and objectives 
Typically, the assessment of the status of the child with autism and the delivery 
of a number of therapeutic interventions are executed within a clinical setting. Of-
ten this approach implies a reduced effectiveness mainly in consideration of: 
a. The “artificial” context of the lab-based environment, which generates the 
potential for artifacts and adds systematic and non-systematic bias to the 
findings, therefore potentially producing results that do not reflect behaviors 
in real life. 
b. The lack of “intensiveness” of the therapeutic intervention (just a few hours 
per week) limiting its beneficial effects, as demonstrated in some recent stud-
ies (11). 
c. The poor “individualization” or “personalization” of the intervention proto-
col, due to a lack of the a priori knowledge of which treatment method will 
be most effective for a specific child.  
 
The MICHELANGELO Project aims to address and overcome these aforemen-
tioned considerations by moving, as much as possible, the assessment and the 
therapeutic interventions from a clinical setting to a more “natural” home envi-
ronment and by using non-obtrusive or minimally invasive techniques. As an ex-
ample, quantitative EEG (QEEG) analysis has proved its capability of identifying 
dysfunction in various regions of the brain in children with autism. Electroenceph-
alogram (EEG) measures brain waves; it shows the variations in electrical poten-
tials at a number of scalp sites. Inside the brain neurons produce their own electri-
cal fields; it is thought that an unhealthy brain will have large changes in the 
electrical potential compared to the potentials produced by a healthy brain.  A 
brain map (quantitative QEEG) could give useful information. 
Unfortunately the invasiveness of the currently used systems induces both sys-
tematic and non-systematic biases to the experimental outcome eluding the actual 
nature of the brainwave behaviour and connectivity.  
MICHELANGELO  intends to minimise the biases and modulation effects by 
making the recording system pervasive in nature so that the patients  becomes 
“unaware” of its presence; it will allow the patients to move freely in their “own” 
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environment while at the same time offering them naturally occurring stimuli and 
continuously monitoring their EEG activities. 
In the pervasive wearable EEG system (a cap of just 60 gr. weight) being used 
within MICHELANGELO, the risk for poor accuracy due to the limited number 
of the employed electrodes (19 electrodes), and to the portability of the system is 
reduced as much as possible by calibrating and adjusting the system according to 
the specific clinical child to be monitored. Throughout the Project, wearable EEG 
recordings has been correlated with those of a dense-array EEG system used as 
“golden standard” and the wearable model adapted and “customized” through the 
optimization of the processing algorithms. In this way, a suitable characterization 
of the brain connectivity of the child and a timely detection of abnormal brain 
waves activity become possible. 
  
Similar studies (12) have reported a change of parameters such as heart rate, sys-
tolic and diastolic pressure, pulse rate, sweat index, body temperature, fingertip 
temperature, electro-dermal activity (EDA) as an effect of the progress in the re-
habilitation program of patients with brain injury. In the MICHELANGELO ‘sys-
tem’ a set of wearable and non-invasive sensors will facilitate the monitoring of 
ECG parameters also.  
Equally important to the quality and accuracy of the interventions and therapies 
is the fact that the MICHELANGELO approach will be extremely cost effective as 
a result of the limited involvement of the medical professionals in spite of the in-
tensiveness of the treatment.   
Another important objective of the MICHELANGELO Project is to open new 
opportunities in the field of ‘personalized’ autism research and treatment.          
Although most researchers agree on the fact that it is necessary to establish an in-
dividualized treatment for each child, very little is known about how to individual-
ize treatment protocols, there have been very few studies in which different meth-
ods have been validated and compared and there is a little knowledge on how to 
determine a priori which intervention is more likely to benefit individual children. 
 ICT can provide a rich understanding of the requirements of each individual and 
allows to monitor them as they develop. It is about realizing a system that recog-
nizes that every child is unique and exhibits unique symptoms and needs and that 
interventions and therapies need to be tailored according to that.  
The MICHELANGELO Project aims to increase the knowledge in these fields 
by comparing the effect of different methods.  
 
10.2.3 The five steps of the Michelangelo approach 
In the diagnosis, characterization and treatment of the children with autism the 
Project proposes an approach that will include the following core steps: 
  
1. The characterization of the child with autism 
 In the specialised medical center a multimodal and unobtrusive system includ-
ing video observation, audio signal analysis, QEEG and other physiological sig-
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nals monitoring (such as heart rate) synchronized all together is used in a con-
trolled environment (the “Michelangelo room”) to observe reactive behaviours of 
children with autism. The developed system allows the analysis and annotation 
(automatic, semi-automatic or manual annotations) of recorded video captured 
during the observations. Advanced solutions allow to maximize the automation of 
the system in detecting “events” i.e. behaviours of the observed child indicating a 
response to the proposed stimuli. The annotations referring to specific behaviours 
of a child are correlated to changes in the characteristics of the captured signals. In 
such a way personalized indicators of the brainwave functionalities under different 
naturally occurring stimuli are identified.  Real time feedbacks are given to the 
therapist to allow him to adapt – when needed – the therapeutic approach and the 
interaction with the child during the session. 
Furthermore multi-modal coordination and interactional synchrony will be ana-
lyzed to get useful insights into the level of rapport between social partners. We 
employ both audio and video analysis to monitor the rhythm and the convergence 
of actions (including communicative and motor function). The system enables to 
evaluate statistically significant correlations between actions (from both intra- and 
inter-personal points of view) and produces an interpretable representation of the 
coordination during interactions (13). 
The stimuli able to generate a response in the child’s brain are analyzed further 
on through the combined use of the wearable Q-EEG system and of an eye-
tracking system. Each one of them is presented to the child on the screen of a PC, 
equipped with an eye tracker which tracks the movement of the child’s eyes and 
records their fixations. At the same time, the brain wave activities are recorded via 
Q-EEG. Different image processing schemes can be initiated on the acquired 
scenes and this will make it possible to determine the nature of the stimulus result-
ing in the brain wave behaviour.  
 
2. Developing an appropriate patient-centric intervention protocol  
Once the above mentioned activities are completed, the findings can be used for 
developing appropriate patient-centric intervention protocol. MICHELANGELO 
intends to explore the benefits of a heterogeneous intervention strategy combining 
neuro-feedback and developmental / behavioural interventions. 
Joint attention and imitation tasks are incorporated in a set of serious games with 
a level of difficulty that evolves depending on the progress of the intervention and 
on the response of the child. The project is developing a methodology for easy ad-
aptation and personalization of the games. 
 
 
3. Therapeutic intervention in a natural environment and the unob-
trusive observation of the child  
The child is monitored during his/her normal daily activities, moving freely      
within a controlled environment while wearing the “QEEG cap” and the other 
physiological sensors. The QEEG system will detect abnormal brain waves and 
trigger a microcamera integrated into the QEEG cap with the objective of tracking 
the specific objects, situations generating this specific brain activity or a change in 
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the monitored physiological parameters. Data monitored at home will be transmit-
ted periodically to the remote Medical Center for further analysis. 
Serious games are proposed to the child and the quality of the execution of the 
planned tasks is automatically assessed by the system and made available to the 
doctor.  
 
4. Adaptation of the therapeutic intervention 
On the basis of the gathered information, the doctor assesses the intermediate 
outcomes of the therapeutic intervention and adapts it by giving information and 
training about the change to the parents of the child. In addition to the periodic 
sessions at the medical center, remote meetings will be planned between the ther-
apist and the parents to share observations, opinions and to strengthen the coop-
eration between them. 
 
5. Periodic assessment at hospital  
In MICHELANGELO the “at-home monitoring” is combined with periodic ad-
vanced lab examinations. The project plans to develop new methods for a better 
analysis of the anatomical and functional brain’s connectivity based on magnetic 
resonance images (DTI and fMRI techniques).  They will allow a better assess-
ment of the evolution of the disorder and of the effect of the therapy. 
  
Fig. 10.5 – The MICHELANGELO approach 
 
10.2.4   Expected advance beyond the state-of-the art  
The MICHELANGELO Project intends to go beyond the state-of-the art in the 
assessment of ASD and the intervention protocols by making possible a remote 
and effective “at-home management” of the autistic children. The recent introduc-
tion of new equipment such as QEEG-, eye-tracking-, diffusion tensor imaging-
based systems and of wearable biomedical devices is providing differential frames 
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to seize invaluable insights, to test hypotheses and collect data that shed new light 
into the nature of typical and atypical developmental processes of social cognition.  
 
MICHELANGELO project will contribute by introducing advanced solutions 
such as: 
 A pervasive wearable EEG system in conjunction with an eye-tracking sys-
tem to record brain wave behaviour when the patient is presented with a 
number of naturally occurring stimuli. According to our knowledge it is the 
first time that these technologies are used together and that eye tracking is 
used to better define the therapeutic intervention rather than to assess and/or 
diagnose the disorder;  
 A wearable, unobtrusive  multi-sensorial platform for the continuous moni-
toring of vital signs able to detect behavioural changes in the autistic chil-
dren; 
 An audio- and video-based system monitoring interactive patterns of the 
child at both motor and communicative levels to detect multi-modal coordi-
nation and interactional synchrony and get useful insights into the level of 
rapport between social partners;  
 A multimodal solution for the patient’s treatment  where neuro-feedback and 
developmental/behavioural intervention techniques are used at home and de-
signed in such way to combine an intensive intervention and the avoidance 
of heavy involvement of the clinicians and therefore to be cost effective; 
 A set of specifically developed serious games and techniques for the assess-
ment of the quality of execution of the game and for the adaptation of its  
level of difficulty and its personalization;  
 A personalization of the overall therapeutic intervention and its timely adap-
tation – in a closed loop approach - according to the feedbacks from the au-
tistic child and the intermediate outcomes of the intervention. 
 
Moreover MICHELANGELO intends to explore and to assess emerging ICT-
based therapeutic techniques such as 3D and virtual reality, computer vision, and 
robotics-based methods. 
 
Progress beyond the state of the art is expected also in specific technological ar-
eas such as: 
a. An advanced system for the analysis and the annotation of recorded videos 
and synchronized QEEG, physiological and audio signals.  
b. Sophisticated signal processing algorithms to remove the redundancies pre-
sent in the traditional Principal Component Analysis (PCA) used to charac-
terize the brain connectivity.  
c. A decision support system helping the therapist in assessing the status of the 
disorder and the response of the child to the presented stimuli and in adapting 
and personalizing the therapeutic intervention accordingly.     
d. Advanced techniques and image processing solutions for the analysis of ana-
tomical and functional brain connectivity made respectively with Diffusion 
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Tensor Imaging (DTI) and Functional Magnetic Resonance Imaging 
(fMRI).The use of these techniques for the assessment of Autism Spectrum 
Disorders and specifically applied to autistic children represents a new field 
of research.   
  
 
10.2.5  Medical, social and economic impact 
 
A. Medical Impact  
The MICHELANGELO project aims at improving the management of ASD in 
children by transferring the treatment from the clinical setting to the more com-
fortable environment of their own homes. There, an intensive and monitored 
treatment and more “natural” conditions will ensure a more accurate assessment 
of the evolution of the disease and will allow a timely adaptation and personali-
zation of the therapeutic treatment. The clinical exploratory study planned in 
the last year of the project will provide a rich set of information that will en-
hance the medical knowledge related to ADS and to the role ICT could play in 
autism. It will include the use of state-of-the art ICT solutions (3D, virtual reali-
ty, robotics) for enhanced developmental / behavioral interventions combined 
with neofeedback-based protocols. Moreover, the outcomes of the project will 
contribute to a research in the ASD field that is still in its infancy i.e. the “a pri-
ori” definition of the right treatment for each individual patient (“individualiza-
tion of the treatment”) and will allow to collect a large quantity of data related 
to ASD. 
 
B.  Social Impact 
The project intends to contribute to the management of ASD, a disease with se-
rious socio-economic impacts and heavy consequences affecting not only the 
patient but all the family members. The MICHELANGELO solution will ena-
ble children with autism to stay in the comfort of their homes, thus reducing 
costs related to therapeutic interventions in external infrastructures with clear 
benefits for the families and the overall community. The final objective will be 
to enhance the chances for a gradual rehabilitation of the autistic child and his 
inclusion in the community. The user-centric approach of the 
MICHELANGELO Project will foster a user-friendly design and minimise the 
intrusiveness of technology.  
By transferring the therapeutic intervention from the hospital to home – it em-
phasizes the role of the parents and of the educators and fosters the cooperation 
between them and the medical professionals; they will participate all together to 
the care process of the autistic child. 
 
C.  Economic Impact 
The MICHELANGELO approach combines intensiveness of the treatment (no 
longer limited to few hours a week at the therapist’s office or at the hospital) 
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with cost effectiveness due to the automation of the treatment asking for a min-
imal intervention by the doctors, even if they are enabled to seamlessly super-
vise, follow-up and monitor the autistic children during the evolution of their 
therapeutic program at home. The MICHELANGELO project helps to put in 
place early therapeutic interventions and it will result in cost saving. As it was 
observed in the EAIS (European Autism Information System) final report (14) 
“the latter is the intervention in the affected child’s life, the greater the time and 
costs involved in providing healthcare and support services”.  
 
10.2.6 Conclusions 
The MICHELANGELO project addresses main societal needs related to health 
as highlighted by the European Commission such as “affordable healthcare 
through cost reduction, new technologies for patient monitoring, diagnostics 
and treatment that allow for better, faster and more cost effective care”. It opens 
new horizons and exploits ICT and other technologies in assessing and treating 
pervasive developmental disorders with specific focus on autistic children.  
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Abstract: This part presents the architecture of an integrated continuous moni-
toring system for Cardiovascular Disease (CVD) patients in nomadic settings de-
veloped under the ARTEMIS-JU CHIRON Project. The proposed sensor platform 
constitutes of commercially available subsystems effectively integrated into a sin-
gle multi-sensor non-invasive wearable solution. To enable medical experts to as-
sess the patient’s condition remotely, a number of analysis algorithm were devel-
oped and implemented into an Android application in order to provide the desired 
medical information. The key challenge in the development of these algorithmic 
solutions, was to balance the expected performance while maintaining a low level 
of power consumption, thus facilitating the continuous monitoring purpose of the 
system. Furthermore, a web-server based framework provides medical experts 
with an interactive analysis and monitoring interface and provides the infrastruc-
ture for storing the obtained data. 
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10.3 Introducing the Proactive Approach in CVD  
World Health Organization (WHO) reports indicate that Cardiovascular diseases 
(CVD) is the most common cause of death in the world accounting for 30% of all-
cause deaths. Recent estimates predict that CVD dominance will continue to raise 
leading to over 20 million deaths in 2015 (Frost & Sullivan 2009). The already 
high associated cost for the treatment and long-term care of CVD patients is also 
expected to follow an incremental trend. As an example the cost for CVD-related 
treatment in the E.U. countries is €169 billion per year, of which 62% accounts for 
direct healthcare costs (Dickstein et. al. 2008). 
By taking into account the related productivity loss and informal care represent  
21% and 17% of the overall CVD costs respectively it is evident that CVD poses a 
a formidable socio-economic burden for developed countries. Due to these facts, 
current conventional care delivery systems are under serious strain with the risk of 
reaching unsustainability in the future unless a pioneering shift in the care delivery 
approach of disease management is initiated. The concept of Proactive Care in-
stead of the conventional Reactive Care approach has been highlighted as the most 
effective model for care delivery in years to come which will enable pre-emptive 
medical intervention and management by prognosticating an impending episode 
even before the full manifestation of the symptoms, leading to a significant de-
crease in death and hospitalization rates.  
For the implementation of such a proactive care system, capturing, processing 
and information fusion of heterogeneous physiological data on a continuous man-
ner in nomadic settings, is a key element. This will be followed by the constant in-
terpretation of the acquired data in a “context-aware” way utilizing established 
medical knowledge. Recent achievements in Information and Communication 
Technology (ICT), in particular in the area of Wireless Sensor Networks (WSN), 
mobile communication and sensor technology have the potential of developing the 
necessary technological background of such a remote healthcare system that is ca-
pable of delivering cost-effective high-quality ubiquitous healthcare. The key 
challenge in the design of such a system is associated with the resource con-
strained nature of wireless embedded nodes, which are typically battery-powered 
devices with only basic processing capabilities. On the contrary, the requirements 
of a remote healthcare monitoring system involve significant computation tasks, 
since almost continuous radio communication and signal processing of data is es-
sential. Hence, in order to achieve long-term, uninterrupted, operation of such a 
system the limited resources of the sensor platforms must be utilized effectively. 
This chapter discusses the development and evaluation of such a remote 
healthcare solution focused on the uninterrupted monitoring of CVD patients. The 
entire system was developed under the Cyclic and person-centric Health manage-
ment: Integrated appRoach for hOme mobile and clinical environments 
(CHIRON) Project. The proposed system constitutes of on-body Electrocardio-
gram (ECG), temperature, sweating index and activity sensors while an Android-
based smart phone acts as the communication gateway and computational plat-
form. In order to facilitate the desired long-term system operation, the designed 
algorithms for the analysis of the physiological data are characterised by their low-
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complexity which maximizes the system’s lifetime. Dedicated firmware has been 
developed for implementing the sensor’s operation and their communication with 
the smartphone.  
According to a review on remote monitoring solutions for CVD patients previ-
ous approaches present several limitations (Klersy et. al. 2009). The majority of 
them makes extensive use of home devices, or ignore parameters that have been 
medically established as indicators of an impending critical cardiovascular epi-
sode, like skin sweating or ST-segment shift with heart rate changes. These docu-
mented shortcomings prompted the development of the CHIRON remote monitor-
ing system. 
In the rest of this chapter, the clinical requirements of the proposed system are 
initially presented in Section II, with the overall system architecture analysed in 
Section III. The design of the individual system components are described in Sec-
tion IV while the system integration is discussed in Section V.  The Medical 
Analysis and Storage subsystem is analyzed in Section VI and conclusions are 
drawn in Section VII. 
 
10.4 Clinical Requirements of a Proactive remote CVD monitor-
ing system 
The fundamental purpose of a Proactive CVD monitoring system is to provide 
clinicians with the necessary physiological data and medical parameters for re-
motely assessing the patient’s overall cardiovascular condition with an acceptable 
degree of confidence. Clearly since the work presented here focuses on CVD, cap-
turing and analyzing the ECG is of paramount importance. Of the same im-
portance as the ECG trace itself, is a number of clinical parameters directly de-
rived from the ECG signal. These metrics, are extensively used in clinical 
cardiology and their value is extracted from the temporal position and amplitude 
value of the constituent waves of the ECG waveform. Other vital signs proven to 
be significant for cardiovascular monitoring and thus included in the CHIRON 
system, are the patient’s skin temperature and skin sweating index. Moreover, in 
the CHIRON system it was decided that an activity recognition mechanism cou-
pled with the calculation of the equivalent metabolic energy value, consumed dur-
ing activities has to be included. Activity data can play a key role in assessing and 
managing the patient’s health status. The inclusion of activity and metabolic ener-
gy expenditure information, is also expected to facilitate the correlation analysis 
among the monitored parameters which may ultimately provide novel predictive 
features that can act as early warning and lead to medical intervention before the 
full manifestation of a critical episode (e.g. myocardial infarction). To the best of 
our knowledge the CHIRON sensor platform is the first attempt in developing a 
fully-integrated solution capable of remotely monitoring all physiological signals 
required for the evaluation of CVD (Pantelopoulos and Bourbakis 2010).  
In order for the system to satisfy its purpose, the aforementioned physiological 
parameters should be monitored in a continuous manner over extended periods of 
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time during the day. This is the pivotal point of the Proactive Care approach as it 
allows to capture the variation in the value of these parameters over time, which is 
considered by medical experts to be the key approach in the attempt to capture the 
decline of the patient’s health and to a further level the prediction of an imminent 
critical episode. 
These clinical requirements posed by the Proactive Care approach yield certain 
engineering and technological challenges that must be addressed. Firstly, exten-
sive uninterrupted monitoring necessitates the development of a non-invasive, 
having a maximum of 3 straps attached to the body’s patient, low-power solution 
able to effectively and robustly communicate the vital signs and relevant parame-
ters from the point of acquisition to the clinician’s remote location. In essence, 
long-term refers to a system capable of acquiring and processing information for 
up to 6-8h during the day. This timeframe is dictated from the fact that CVD pa-
tients will not tolerate to bear such a system for more time during the day. To ac-
commodate the clinical requirements described in this section, a customized sen-
sor-platform and its corresponding system architecture was developed and 
presented in details in the following sections. 
 
10.5 System Architecture 
The sensor platform of the CHIRON system comprises of 4 sensor devices. 
Specifically, 1 ECG single-lead sensor, 1 temperature/sweating index (TS) sensor 
and 2 3-axis accelerometers are employed. From the data captured by the 2 accel-
erometers the patient’s activity and energy expenditure are derived. The 4 sensor 
devices are embedded in 3 sensor modules, powered with rechargeable batteries, 
attached to 2 elastic straps, resulting in a total of 3 separate platforms positioned in 
the patient’s body. The first strap is a chest belt designated to be attached in the 
patient’s upper abdomen/lower thorax area containing the ECG module and an in-
tegrated accelerometer-temp/sweat (ATS) module. The second strap places the 
second accelerometer module on the patient’s thigh area. The 3 sensor modules 
collect readings from the 4 sensors and transmit them wirelessly, using the wire-
less Bluetooth (BT) standard, to the information processing platform (IPP). A pic-
torial representation of the wearable sensor system is provided in Fig. 10.6. 
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Fig. 10.6 – The configuration of the integrated wearable sensor platform. 
 
 The IPP constitutes an Android-based smartphone, tasked with fusing and 
processing the incoming sensor data while also providing the user interface. Apart 
from the TS data the rest of the sensor readings are subjected to specific signal 
processing for the extraction of the clinical ECG parameters, the identification of 
the patient’s activity and finally the calculation of the energy expenditure. For 
these operations a customized Java-Android application (pIPP) was developed 
which includes the processing routines for the ECG and accelerometer data. In ad-
dition, to provide cardiologists, apart from the value of the EGC parameters, with 
the ECG trace itself, a compression scheme has been included to decrease the 
amount of ECG data that need to be communicated from the IPP to the medical 
analysis and storage subsystem (MASS). The MASS is a server-based framework 
providing medical experts with visualization and analysis tools for effectively 
monitoring the captured data. The raw physiological readings and the analysis 
outcomes are communicated to the MASS from the IPP through FTP protocol 
over wireless 3G data connection. This choice was dictated by the fact that 3G of-
fers much wider coverage than any other wireless standard, allowing for data 
transmission to be taking place without the need of the patient being constrained 
to a specific area. To provide cardiologists with the ability to monitor the patient’s 
status “anytime” a second Java-Android application (mIPP) which connects to the 
MASS and upon request downloads data and displays them in a handheld device 
(tablet/smartphone) was built.  
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Based on the above architecture, two operational modes were defined. In the 
real-time streaming mode, data are transmitted to the IPP in real-time while the 
processing outcomes are uploaded on the MASS at the moment of their produc-
tion. Data and medical parameters are then accessed from medical experts with 
minimum latency. Under this mode, clinicians obtain a real-time assessment of the 
patient.   
Although energy demanding, due to the continuous BT transmission, the real-
time mode is ideal for patients in high risk of an impending episode or in situa-
tions where the clinician wishes to perform a remote stress test, by instructing the 
patient to walk on a treadmill while monitored. The second operational mode is 
the one expected to be utilized under normal conditions. In this mode, sensor data 
are not transmitted to the IPP in real-time. Instead, data are time stamped and lo-
cally stored to the communication modules during sensing. Once sensing is com-
pleted data transmission and processing on the IPP takes place in batch mode. The 
final outcomes are then uploaded and stored to the MASS. Medical experts can 
then access data through queries at will and thanks to timestamping, correlate and 
combine readings and outcomes obtained from different sensors. The IPP governs 
which operational mode is in use by commands issued to the sensor modules, 
which upon request can set their mode of operation. 
 
      
10.6 Sensor Components 
The sensor modules utilized in the CHIRON sensor platform are based on the 
Shimmer WSN module. The standard Shimmer platform is based on a T.I. 
MSP430F1611 microcontroller, which operates at a maximum frequency of 8 
MHz and is equipped with 10Kb RAM and 48 Kb of Flash. An 8-channel 12-bit 
A/D converter enables connectivity with various sensors (ECG, EEG, accel, gyro, 
etc…). Wireless communication is achieved either with class 2 BT (RN-42 mod-
ule) or through IEEE 802.15.4 (T.I. CC2420 module.). The standard BT v2 was 
elected as the sensor modules communication standard. For storage purposes the 
Shimmer platform is equipped with an integrated 2GB microSD card which is 
used in normal operation mode to store sensor readings (Burns et. al. 2010). The 
power supply is comprised of a 450mAh rechargeable Li-ion battery. Finally the 
Shimmer platform is designed to be programmed with the open-source TinyOS 
operating system (Levis et. al 2005).  
10.6.1 ECG Sensor 
The standard Shimmer ECG platform uses 4 snap electrodes attached through 
wires and medical patches to the body. It was thus deemed to be too invasive for 
the long-term monitoring purposes of the CHIRON system. The Shimmer ECG 
module was redesigned by replacing the 4 snap electrodes with 2 dry electrodes 
that can be attached to a commercially available chest strap (i.e. Polar®, Adidas®) 
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and provide a single ECG lead. The resulting solution, depicted in Fig. 10.7, is 
lightweight (~80 g) with minimal invasiveness without any need for skin prepara-
tion or adhesive gels.  
An analog front end with high gain and low cut-off frequency is necessary to 
condition the raw ECG signal and remove the noise for digital conversion and 
processing. The Shimmer ECG board has a low power front-end data acquisition 
circuit, composed by analog amplifiers and filters able to reduce the artefacts of 
movement, respiration and muscle contraction and to reach the desired dynamic 
range. The frequency response is 0.05 to 150 Hz with an amplifier gain of 175. 
The collected analog signal is then sampled through an A/D converter with 12-bit 
resolution. The digitized data are then passed to the microcontroller (MSP430) for 
processing and storage through a USART serial connection bus. 
 
Fig. 10.7 – The customized ECG sensor. 
 
It was determined that in order to extract all necessary medical parameters, the 
ECG signal must be sampled at a frequency of at least 500 Hz. The quality of the 
acquired ECG signal from the customized platform was evaluated in hospital bed-
side settings as well as during a marathon run. Additional experiments were per-
formed and the ECG was captured by both the CHIRON ECG chest strap and the 
Holter ELA device (considered as the golden standard for ambulatory ECG) sim-
ultaneously. The obtained waveform confirmed that the signal quality was compa-
rable to the one acquired by the gold standard Holter. A comparison of bedside re-
cordings demonstrated that the CHIRON chest strap recordings produce a similar 
waveform to the one captured by standard ECG machines as shown in Fig. 10.8. 
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Fig. 10.8 – Comparison of ECG chest strap recordings with a standard ECG 
machine at bedside settings. 
 
The CHIRON ECG chest strap was also used to obtain the ECG of runners par-
ticipating in a marathon. As depicted in Fig. 10.9 the ECG signal appears stable 
and with a negligible number of artifacts. 
 
Fig. 10.9 – Three portions of ECG chest strap recordings of a runner during a 
marathon with different heart rates. 
 
Additional tests were performed in 5 subjects having their ECG captured at 
bedside settings for 3 hours using both the CHIRON ECG chest strap and the 
Holter ELA. The ECG chest strap provided readable signal for more than 95% and 
99% of the time of acquisition while the subjects were on working and lying su-
pine at bedside respectively. Following, the ECG signals from both devices were 
analyzed and the heart rate (HR) of the subjects was derived from both devices. 
As it can be seen in Fig. 10.10, the two tachograms are almost identical and the 
low value of the mean error distribution, (~0.01 sec), as depicted in Fig. 10.11 
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confirms the similarity of the ECG signals acquired by the two devices. In addi-
tion, this investigation justifies the ability to derive medical important parameters 
from the CHIRON ECG chest strap with a similar level of accuracy as with golden 
standard devices. 
 
Fig. 10.10 – Comparison of the tachograms produces from the ECG chest strap 
and the ELA Holter. 
 
Fig. 10.11 – ECG chest strap tachogram error distribution with respect to 
Holter ELA. 
10.6.2 Accelerometers  
Accelerometers are utilized in the CHIRON system in order to provide the re-
quired data for activity recognition and metabolic energy calculation. Two Shim-
mer platforms, each containing a 3-axis accelerometer (Freescale MMA7361) are 
used in the CHIRON sensor platform. The two accelerometers are placed on the 
chest and the thigh. These positions were chosen based on the achieved activity 
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recognition performance on preliminary tests (analyzed in Section V). The sam-
pling frequency for the accelerometers was set at 50 Hz. 
10.6.3 Temperature/Sweat Index Sensor (TS) 
Clinical specifications for skin temperature and sweating index measurements 
dictate not to use more than one patches for collecting both temperature and sweat 
index data. Subsequently, a sensor combining both capabilities was developed. 
The accuracy of the sensor should be better than ±0.5 ºC error with a measurement 
rate of one temperature and sweat index sample per five minutes. In order to satis-
fy these specifications, the Sensirion SHT21 digital sensor was chosen (Sensirion). 
This sensor is a suitable choice for temperature and sweat index measurements, as 
it integrates both a temperature and a humidity sensor, used to obtain sweat index 
data by measuring the relative skin humidity. The Sensirion SHT21 sensor is also 
suitable for the purposes of the CHIRON system in terms of size, accuracy and 
low-power consumption in both active and sleep mode. Table 1 summarizes the 
TS sensor characteristics. 
 
Table 1: Temperature and sweat index sensor characteristics 
Description Value Units 
Sensor size 3X3 mm2 
Active power consumption 1 mW 
Sleep power consumption 1.2 uW 
Humidity range 0-100 %RH 
Humidity accuracy ±5 %RH 
Humidity resolution 0.04 %RH 
Temperature range 0-60 ºC 
Temperature accuracy 0.3 ºC 
Temperature resolution 0.04 ºC 
 
The TS sensor is placed under the patient’s armpit a common place for acquir-
ing temperature and sweat index measurements (Sund-Levander et. al. 2004). In 
the CHIRON system the TS sensor is connected to the Shimmer accelerometer 
module attached to the chest strap (through the I2C bus) as shown in Fig.10.12. 
Temperature and sweating index values are sampled once every 5 minutes. Sam-
ples are combined with the accelerometer data in a single message format and ei-
ther stored or sent to the IPP. The platform was tested at a higher rate, i.e. every 
20 seconds, in order to also check the autonomy of the sensor together with BT 
Shimmer module communications. Experiments were conducted with a volunteer 
wearing the sensor while performing different activities. Fig. 10.13 shows the 
temperature and relative humidity of the volunteer who performed low physically 
demanding activities (e.g. sitting down or walking) until 7 p.m. when the volun-
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teer changed to a moderate activity, (e.g. climbing stairs) for 15 minutes that re-
sulted in sweating. 
  
Fig. 10.12 – Prototype of the temp sweat index sensor connected to the Shim-
mer acceleration module.  
 
Results in Fig. 10.13 show a noticeable increment on humidity with a subse-
quent decrease when sweating stops. Concerning the results of the temperature, 
they are coherent with auxiliary temperature values and with temperature daily 
rhythms (Sund-Levander et. al. 2002; Monk et. al. 1995). 
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Fig. 10.13 – Skin temperature and relative humidity (sweat index) results for 8 
hours of continuous monitoring and for different physically demanding activities. 
 
The sensor platform was also tested in a DYCOMETAL CCM81 climatic 
chamber with the chamber humidity being varied from 40% to 90% in 2-hour cy-
cles for a period of 20 hours while keeping the temperature constant at 36ºC. From 
Fig. 10.14, it is clear that the sensor follows the humidity variations almost instan-
taneously. This experiment also reveals that the autonomy of the platform exceeds 
20 h at 20 sec sample rate.  
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Fig. 10.14 – Sensor test for twenty hours of continuous data acquisition. The 
humidity varies from 40% to 90% in 2-hour cycles while the temperature is kept 
constant at 36ºC. 
10.6.4 System Integration 
10.6.4.1 Modules Packaging 
The 4 sensor modules were packaged into a single wearable system. The POLAR 
chest belt was used and customized to provide encapsulation for both the ECG 
module and the combined ATS module placed on the chest. Also the two Shimmer 
modules in the chest belt had their charging ports connected so the user can re-
charge them without removing them from their encapsulation. Fig. 10.15 illus-
trates the enclosure of the two sensor modules and the placement of the strap on 
the lower thorax area. The ECG module and the ATS module weight, 28g and 22g 
respectively. The overall weight of the chest strap is less than 100 g, resulting in a 
non-invasive lightweight solution. 
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Fig.2.15 – The chest strap encapsulating the sensor modules 
 
10.6.4.2 Firmware Development- Operational Protocol 
To achieve the dual-mode functionality, imposed by the clinical requirements, 
all three Shimmer modules were programmed with both the ability to store sensor 
readings in their SD-card (with the BT turned off) or stream the readings through 
BT to the IPP. The user operational protocol was designed with two things in 
mind. The first was to minimize, as much as possible, the actions needed to be 
performed by the user and secondly to provide an energy-efficient strategy that 
would ensure a smooth uninterrupted operation. Subsequently the operational pro-
tocol was formed as following. Initially the sensor platforms are being charged on 
their docking stations with the BT “on” awaiting commands from the IPP. The re-
quired BT pairing of sensor modules to the IPP has taken place before the de-
ployment of the system. The user removes the platforms and places them on 
his/her body to begin sensing. 
Following the IPP sets the mode of operation to real-time and performs a sanity 
check on the correctness of the sensor placement. If this check fails the user is in-
structed to reposition the sensors appropriately. Once the IPP recognizes that the 
sensors are correctly placed, broadcasts a command with the current IPP time to 
all modules to swap to normal operation mode. The sensor modules then turn the 
BT radio “off” and start logging data in their SD card. Once the logging period is 
over the user places the platforms at the docking stations again and the platforms 
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turn “on” their BT. At this point the IPP requests the log, from each sensor, which 
contains information on the size of stored data. Then the IPP requests the stored 
data samples which are transmitted in batch mode. During data transmission, the 
platforms battery is recharged and a new operational cycle begins the next time 
(e.g. following day) that sensing must take place.  
The sensor platforms customized firmware was developed in the TinyOS oper-
ating system. For the ECG sensor and the thigh accelerometer the typical TinyOS 
sensor components and interfaces were used to develop the sensor’s firmware. On 
the other hand, the functionality of the ATS module had to be implemented. The 
TS sensor was integrated in the Shimmer module and connected to the I2C bus of 
the MSP430 microcontroller. A TinyOS interface was built in the stack layer to 
receive the TS data when necessary. The firmware for the ATS module employs 
both the accelerometer and TS interfaces in different sampling times.  
In order to minimise the overall power consumption of the sensor platforms the 
BT module was kept “off”, apart from when data are transmitted to the IPP either 
in real-time mode or in batches from the SD-cards at the end of sensing during the 
normal-mode. Predefined external events and commands produced by the IPP and 
formulated as TinyOS commands were used in order to trigger the swap, from one 
mode of operation to the other, initiate sensing and communication and govern the 
overall operation of the sensing platforms. Fig. 10.16 illustrates the block diagram 
of an operational cycle and the commands and events that are generated. Fig. 
10.17 shows an analytical flow chart of the firmware that was developed for the 
ATS sensor platform. The description of the commands is as following. 
 
Commands initiated by the IPP: 
• Real-time operation: The sensor platform sample data at various frequen-
cies (depending on the sensor) and sends each sample to the IPP. 
• Normal operation: Platform stops Real-time transmission and wait for the 
absolute real timestamp from the IPP. The timestamp is written at the beginning of 
each log file and used as a reference for reconstructing the timestamp of each data 
sample. Following, the sensor platform turns its BT off and start logging data. No 
communication link exists between the sensor platform and the IPP during the 
logging process. 
• Is Log Available: The platform checks if the log file is available and 
sends the status to the IPP. 
• Send Log: The platforms send the log file. First, the absolute timestamp 
is sent, and then the data samples  
• Delete Log: Platform deletes the log file. 
 
Sensor Event: 
• Docking event (the sensor is put on the charger after normal operation): 
The platform stops logging and turns on the BT. Yellow LED is turned on, indi-
cating that the log file is ready to be sent.  
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Fig. 30.16 – The operational cycle of the normal (SD-logging) mode of opera-
tion 
 
10.6.4.3 Data generation 
Considering the Shimmer platforms specifications an analysis follows on the 
amount of data expected to be generated on a daily basis. Firstly, the MSP430 A/D 
channels perform 12-bit (2 bytes of storage) digitization and that a 16 bit (2 bytes) 
timestamp is stored for each sample, Table 2 summarizes our projections based on 
the sampling frequency of every sensor. Based on these calculations the total 
amount of data for 6-8h of daily use should be 57.5Mb – 76.2Mb. This amount of 
data does not pose any issue in any operational mode, since in the real-time sce-
nario BT can achieve datarates up to 300kbps which is more than adequate for the 
amount of data generated per second and in the logging operating mode the micro-
SD cards on the modules have more than enough capacity to store the generated 
data. 
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Fig. 10.17 – ATS platform firmware flow chart 
 
 
Table 2: Projected Sensor data generation on a daily basis 
Sensor Module Sampling Fre-
quency (Hz) 
Data per 
sec (KB/s) 
Data per hour 
(MB/h) 
ECG 500 1.95 6.85 
2*Accelerometer 
(3-axis) 
50 0.78 2.74 
Temp/sweat index 0.0033 0.0264
B/s 
0.0009 
Total  3.89 9.59 
 
10.6.4.4 Energy Profiling 
A crucial part, of the CHIRON system is to ensure that the energy consumption 
of the various system components is such, that under any mode of operation the 
clinical requirements are fully met. The energy consumption analysis of the 
Shimmer platform, presented in (Burns et. al. 2010), designates the ECG to be the 
most energy demanding module in the SD-logging mode drawing an average of 
4.5mA at 500 Hz, compared to the accelerometer which draws 1.6mA at 50Hz. 
When the modules stream data in real-time through the BT the consumption in-
creases to 21.1 mA and 15.9 mA for the ECG at 500Hz and the accelerometer at 
50 Hz, respectively. The consumption of the T/H sensor is negligible since the 
Sensirion SHT21 sensor draws only 300μA during operation and its sampling fre-
quency is very small. The same analysis also states that an ECG module operating 
at 500 Hz can log data generated at the rate of TABLE II, in the micro-SD card or 
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stream them in real-time via BT for at least 48h and 12h respectively considering a 
280 mAh battery without any energy management protocol. From this analysis, it 
is safe to assume, that since the same hardware equipped with a 450 mAh battery 
is used the clinical requirement of 6-8h data logging (in the storing mode) or an 
adequate amount of time (~1h) for live streaming (streaming mode) can be easily 
met, provided that the module’s batteries are fully charged at the beginning of 
sensing. Table 3 lists the maximum battery lifetime of the three sensors compo-
nents as obtained from a series of experiments. 
 
 
 
Table 3: Maximum Battery Lifetime for the three sensor components 
 
Sensor Module Maximum Battery lifetime 
 
            Real-Time mode         SD-logging mode 
ECG 8 h 100 h (4 days) 
Accelerometer 18h 30m 14 days 
ATS module - 8 days 
 
10.7 Information Processing Platform (IPP) 
The IPP has a central role in the CHIRON monitoring system. Sensor data are 
fused in the IPP and processed accordingly. The IPP also governs the operation of 
the sensor modules and provides the user interface. It was decided that a latest 
generation Android-based smartphone would be the best selection for the IPP. 
Smartphones are universal devices with which users feel familiar. This is particu-
larly useful since it will result in a small learning curve for both types of users. In 
addition, users normally carry smartphones almost all the time, which is ideal for 
the continuous monitoring scenario under consideration. Latest generation 
smartphones are equipped with powerful microprocessors and wireless connectivi-
ty chipsets which guarantee that the desired IPP operations can effectively run on 
such devices. 
10.7.1 Analysis Algorithms 
The data analysis algorithms comprise of the ECG analysis, which leads to the 
extraction of several medical parameters from the ECG signal and the activity 
recognition and metabolic energy calculation (ARMEC) algorithms, which use the 
accelerometer data as inputs. The temp/sweat-index data are not subjected to any 
processing and are simply fused to the MASS.   
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10.7.1.1 ECG Feature Extraction and Compression 
For the ECG analysis the main demands are to provide clinicians with the re-
quired ECG-related parameters as well with the ECG waveform itself. Since the 
ECG provides a direct representation of the heart's electrical activity, cardiologists 
have defined a number of ECG parameters that are used for the evaluation of the 
heart's condition. These features are either morphological (e.g. R-height) or tem-
poral (e.g. QRS-duration, QT-interval, ST-segment, etc). Fig. 10.18 illustrates a 
typical PQRST-complex and the relevant ECG features. Evaluation takes place by 
examining the morphology of the waveform and the value of the clinically im-
portant parameters. For example, a prolonged QT-interval is a biomarker of ar-
rhythmia, while an elongated QRS may be indicative of bundle branch block.  The 
estimation of the aforementioned parameters requires the detection of a total of 11 
time instances within a single ECG heartbeat (PQRST-complex). In details, the 
onset and offset instances of the P-wave, the QRS-complex and the T-wave, as 
well as the time instance of the peak of each wave (P, Q, R ,S, T) must be extract-
ed. By obtaining this set of 11 time points, all the relevant temporal ECG parame-
ters can be calculated. Additionally, parameters defined between successive heart-
beats (e.g. P-P interval, R-R interval) can also be approximated. 
 
Fig. 10.18 – The ECG Parameters. 
 
A novel algorithmic solution, was subsequently developed which not only 
achieves the approximation of the ECG parameters with comparable to the state-
of-the-art accuracy, but also allows for an effective ECG compression scheme to 
be applied in parallel. This dual feat is achieved by employing the Haar Discrete 
Wavelet Transform (DWT) as the primary analysis tool. The DWT is realised as a 
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cascaded filter bank using high and low pass filters defined according to the moth-
er Wavelet and its scaling function. The output of the high pass filters provides the 
detailed coefficients (cD) and the output of the low pas filter the approximate co-
efficients (cA). The structure is known as Mallat’s algorithm and allows for multi-
level DWT decomposition to be performed by using the cA coefficients of a level 
as the output to the next pair of filters. It is established that due to the nature of the 
Haar function, potential extrema points in the input signal, will be represented as 
zero-crossing points in the cD coefficients and deflection points will be mapped 
into extrema in the DWT coefficients. By considering a single PQRST-complex 
and within it, the boundaries of the ECG waves as deflection points and their 
peaks as local extrema points, DWT multilevel decomposition in the dyadic space 
is performed and by using the aforementioned principle temporal points of the 
constituent waves of the ECG and the temporal location of the peak of each wave 
was extracted.  Analytical details and performance results of the HFEA algorithm 
that was developed specifically for the CHIRON system can be found in (Mazo-
menos et. al. 2013). The key novelty of the HFEA algorithm is the fact that it 
achieves comparable performance to the state-of-the-art ECG delineators while its 
computational complexity, in terms of mathematical operations required for its 
completion, is approximately 5 orders of magnitude smaller than that of the-state-
of-the-art ECG delineators. It therefore provides an ideal solution for the continu-
ous CVD monitoring nature of the CHIRON system. 
Of all the ECG parameters (see Fig. 10.18) starting at the QRSoff and finishing 
at the Ton) carries significant clinical information and is of great value for the di-
agnosis of ischemic episodes and for the evaluation of the amount of oxygen sup-
plied by the coronary arteries to the myocardium. Therefore, following the cardi-
ologists guidelines, the ST-segment after being localised by the HFEA was 
subjected to additional processing for the calculation of a number of specific ST-
segment medical parameters. Namely the ST-slope, the slope of the line connect-
ing QRSoff and Ton points, the ST-deviation, the amplitude deviation of the ST-
segment from the isoelectric line, the ST-area1, the area under the ECG waveform 
between the two ST-segment temporal boundaries when considering the isoelec-
tric line as reference and the ST-area2, the area under the ECG waveform between 
the ST-segment temporal boundaries when considering the ST-line (line connect-
ing QRSoff and Ton) as a reference were calculated using the Simpson rule. In to-
tal 20 ECG parameters are produced from the HFEA and the ST-analysis routines 
per heartbeat. These are either stored on the SD-card of the ECG module or 
transmitted directly to the IPP depending on the operational mode.  
Finally the raw ECG data are also stored/transmitted in a compressed form. As 
analysed in Section IV the majority of the generated data will be a result of the 
high sampling frequency (500Hz) of the ECG Sensor. Moreover the clinical re-
quirements dictate that clinicians must have access to the full ECG waveform 
apart from the value of the ECG parameters. This posed a requirement for an effi-
cient compression technique to be implemented alongside the HFEA algorithm. 
Since the DWT is utilized in the HFEA the inherent ability of DWT for compres-
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sion and reconstruction of non-stationary signals was also exploited. Compression 
is achieved inherently in DWT because the frequency spectrum of the original 
signal is halved after each level of the DWT filter bank. Subsequently the output 
of the high and low-pass filters is subsampled, by a factor of 2 which discards half 
of the samples of the input signal and eliminates redundancy. Combined with a 
thresholding technique, based on the investigation of the Energy Packing Efficien-
cy (EPE) of the resulting DWT coefficients, the compression scheme used in the 
CHIRON system maintains and store only those DWT coefficients that have a 
significant contribution to the energy of the signal. This is achieved by storing on-
ly the coefficients that have higher amplitude than a percentage of the maximum 
coefficient at that level. Reconstruction is achieved in a similar way that DWT de-
composes the signal in cA and cD coefficients. The inverse DWT (IDWT) can re-
construct the signal from cA and cD coefficients using synthesis filters. Previous 
work reveals that the aforementioned compression method can achieve compres-
sion ratios of 16.5:1 and a percentage root mean square difference of 0.75 (Biswas 
et. al 2012). 
 
10.7.1.2 Activity Recognition and Metabolic Energy Calcula-
tion (ARMEC) 
The Activity Recognition and Metabolic Energy Calculation subsystem recog-
nizes basic activities and estimates the patient’s energy expenditure. To develop 
and test these methods, recordings of physiological signals during activities with 
different energy expenditures were made. The recordings consisted of accelera-
tion, heart rate and skin temperature data used for activity recognition and energy 
expenditure estimation. Reference energy expenditure was provided by indirect 
calorimetry, and true activities were labelled by an observer.  The reference ener-
gy expenditure was measured by Cosmed K4b portable gas analyser (Cosmed 
K4b), which computes the metabolic activity through the analysis of inhaled and 
exhaled gases. The recordings were made by ten subjects performing the basic ac-
tivities to be recognized as listed in Table 1. The energy expenditure values are 
expressed in MET (metabolic equivalent of task, 1 MET corresponds to the aver-
age energy expenditure at rest), and are averaged over all ten test subject to pro-
vide an indication of the mean energy expenditure of each activity. Both the ac-
tivity recognition and energy expenditure calculation were essentially tackled in 
the same way. The stream of acceleration measurements was split into windows, 
each window overlapping with the previous one by one half of its length. Several 
attributes were computed from the acceleration data within each window. These 
attributes formed a vector, which was fed into a machine learning algorithm. The 
algorithm constructed a model which either recognized the activity within the 
window or estimated the energy expenditure based on the average energy expendi-
ture of Table.1. The output of the activity recognition model was the used as input 
to the energy expenditure estimation model. 
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Table 4: Activities in the test scenario 
Activity Basic Energy (MET) 
Lying Y 1.19 
Sitting Y 1.26 
Standing Y 1.26 
Walking Y   
... slowly (4 km/h)   3.50 
... quickly (6 km/h)   5.03 
Running slowly (8 km/h) Y 7.80 
Stationary cycling Y   
... lightly (1 W / kg of body mass)   4.91 
... vigorously (1 W / kg of body mass)   7.22 
Kneeling Y 1.30 
On all fours Y 1.77 
Lying doing light exercise   1.28 
Sitting doing light activities   2.30 
Walking doing light chores   2.30 
Scrubbing the floor   2.65 
Shoveling snow, digging   3.40 
 
To reduce the number of attributes thus the computational complexity and 
power consumption, attribute selection was applied to the attribute sets of each of 
the two models. First, the quality of all the attributes was estimated using the Re-
liefF method (Kononenko et. al. 1994). The attributes were then ranked by their 
ReliefF score. Second, the attributes were removed from the attribute set one-by-
one, starting with the lowest- ranked one. After each attribute was removed, the 
classification/regression accuracy was tested using cross-validation. The removal 
of low-ranked attributes slightly increased the accuracy, then the accuracy plat-
eaued, and finally the removal of high-ranked attributes decreased the accuracy. 
The final attribute set consisted only of the attributes whose removal decreased the 
accuracy. The models were tested using the leave-one-person-out method. This 
means that the model was trained (including attribute selection) on nine test sub-
jects and tested on the tenth. The procedure was repeated ten times, using a differ-
ent subject for testing each time. This procedure estimates the performance on a 
previously unseen person. 
A. Activity Recognition 
Since the user’s activity is changing over time, it should be recognized with an 
appropriate frequency. Prior work demonstrated that 2 sec windows are a reasona-
ble trade-off between the overall recognition accuracy (increases with window 
length) and the ability to recognize very short activities (decreases with window 
length), so considering the 50 Hz sampling frequency of the two accelerometers 
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each window contains approximately 100 acceleration measurements (Žbogar et. 
al. 2012). 
From these, 128 attributes per window were computed, drawn from previous 
works (Gjoreski 2011, Tapia 2008). Attribute selection using the RelieF method 
reduced the number of attributes to 41. The attributes were computed from data 
processed by either a low-pass filter (to single out the acceleration component re-
lated to the user’s posture, which changes infrequently) or a band-pass filter (to 
single out the acceleration component related to the user’s motion, whose frequen-
cy is above the frequency of posture changes and below the frequency of sensor 
noise).  
 
Prior work on activity recognition with accelerometer data showed that the 
Random Forest algorithm is the most suitable for this task (Gjoreski et. al. 2011). 
The attributes were thus used to train and test a Random Forest activity-recogntion 
model, using the Weka machine. With the reduced attribute set (41 attributes), the 
classification accuracy was 92.0%, which was a 0.8 percentage point increase 
compared to the full attribute set with 91.2% classification accuracy. Although the 
difference in accuracy is not statistically significant, the computational complexity 
was reduced, due to both reducing the number of attributes in the model and by 
removing the calculation of attributes with complexity above linear in each win-
dow (energy, entropy, ...) which require the computation of Fourier transform. 
This improves the battery life and speeds up the recognition process. 
 
B. Metabolic Energy Calculation 
Since longer time is needed to estimate the energy expenditure, windows of 10 
sec were used (Luštrek et. al 2012). Each window contained approximately 500 
acceleration measurements and 10 heart rate and 10 skin temperature measure-
ments. For each window, 137 attributes were computed, 135 from accelerometer 
data, one was the heart rate and one the skin temperature. Attribute selection re-
duced the number of attributes to 29. Among these 29 attributes 5 require the cal-
culation of Fourier transform, which was removed to decrease the computational 
complexity.  
It was verified, through experimentation that the Support Vector Regression 
(SVR) algorithm, yields optimum results in estimating the energy expenditure es-
timation (Luštrek et al 2012). Again the Weka framework was used to train and 
test the SVR model. The accuracy of the model in terms of mean absolute error 
(MEA) was 0.67 MET. The analysis of the error showed that the largest error oc-
curred in the cases of running and cycling. To overcome this problem, two addi-
tional regression models were trained specifically for these two activities. This re-
sulted in three regression models: two trained on running and cycling and used to 
estimate the energy expenditure on these two activities, and one trained on all ac-
tivities and used on all activities except running and cycling (training on all activi-
ties increased the robustness in case running and cycling were misclassified by the 
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activity-recognition model). All models were again trained with the SVR algo-
rithm. The approach with three models resulted in MEA of 0.56 MET, a decrease 
of by 0.11 MET. Fig. 10.19 illustrates the true vs. the estimated energy expendi-
tures. On the x-axis are the true MET values and on the y-axis the estimated MET 
values. 
 
 
Fig. 10.19 – True vs Estimated Energy Expenditure 
 
10.7.2 IPP Application 
The IPP provides the user interface to both groups of users; medical experts 
and CVD patients. Subsequently two separate Android-based applications were 
developed that implement the functionality of the IPP for each user group – pa-
tient/user and medical experts. 
10.7.2.1 Patient IPP (pIPP) 
The IPP of the patient/user (pIPP) has the role of the gateway of the sensor 
plane analyzed previously. It is responsible for setting the desired mode of opera-
tion, synchronizing the data from the sensor modules, fusing the sensor data, exe-
cuting the analysis algorithms and ultimately transferring outcomes and com-
pressed data to the MASS. To implement these operations an Android-based 
application was developed and its overall architecture is given in Fig. 10.20.  
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Fig. 10.20 – Schematic Diagram of the IPP-app 
 
To begin sensing, the patient attaches the two straps (chest and thigh) to his/her 
body, and initiates the system by pressing the “start sensing” button on the pIPP. 
The pIPP establishes communication with the 3 sensor modules through BT and 
depending on the mode of operation acquires the sensor readings either in real-
time or off-line, from the Shimmer modules SD-card at the end of sensing. Latest 
BT modules attached on Android smartphones are more than capable of simulta-
neously maintaining the link and communicating to multiple BT modules. The 
pIPP sets the appropriate operational mode by transmitting commands through the 
BT link to the sensor modules.  The core of the pIPP contains the two analysis 
packages of the ECG and ARMEC, both implemented in Java language as per the 
Android OS requirements. Again the operational mode dictates the execution of 
the two algorithms either in real-time or off-line. Moreover the IPP-App is also 
tasked with conveying the algorithm’s outcomes to the MASS through 3G wire-
less communications.   
The analysis algorithms are also used to evaluate the quality of the received da-
ta and affirm the correct placement of the sensor modules before the beginning of 
sensing. This sanity check stage takes place in the pIPP, after the patient “starts 
sensing”, by setting the system in real-time operation and evaluating the algo-
rithm’s outcomes. The patient is instructed to lie down for 30 sec and then stand 
for another 30 sec in order to confirm the output of the activity recognition subsys-
tem. The ECG signal is evaluated by investigating the soundness of the HFEA re-
sults for 2 min.  If one of the modules is found to be misplaced the user is then in-
structed to reattach it.  
The pIPP uses the smartphone’s real-time clock to inform the patient when 
monitoring must stop.  In addition the pIPP is tasked with synchronizing the data 
received from the three sensor modules. Synchronization is critical as the ARMEC 
algorithms require the data from the two accelerometers to be synchronized.  In 
addition, data synchronization facilitates the correlation analysis of different phys-
iological parameters to take place (ECG parameters, activity) a requirement posed 
by the medical experts. Synchronization was achieved using the “start sensing” 
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command as reference and the Shimmer counter timestamp stored with every data 
sample. Each data sample is then labelled with a global timestamp by the IPP. 
This method will of course suffer from the inaccuracy of the Shimmer internal 
crystal clock (Epson FC-135 32.7680KA-A3) which has a tolerance of ±20 ppm, 
which results in 1.8 seconds maximal drift in 24 h. In the worst case scenario, 
when two sensors have different drift directions, the time difference is 3.6 s. How-
ever, in the CHIRON system a maximum of 6h continuous logging is expected, 
which would result in a maximum drift of 0.9 s, which is acceptable for the task of 
activity recognition and energy expenditure. Experiments carried out showed that 
no significant drift was present after 6 h and a time difference of 0.3s was ob-
served among the 2 accelerometers after 24h of continuous logging.  
The user interface of the pIPP was designed in such a way as to require mini-
mum intervention from the user. In essence the user need to simply click the 
“START” and the pIPP takes over and instructs the user to go through the sanity 
check and then the normal sensing session begins. Moreover, the pIPP offers a re-
port interface where the patient/user can manually input the value of a number of 
medical parameters (blood pressure, weight, etc..) not measured by the CHIRON 
system. An illustration of the pIPP user interface is provided in Fig. 10.21. 
 
 
Fig. 40.21 – The user interface of the pIPP 
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10.7.2.2 Medical Expert IPP (mIPP) 
The Android-based application designed for the medical expert user of the 
CHIRON system constitutes a monitoring interface in which medical experts can 
obtain the values of all parameters, measured by the sensors or produced from the 
analysis of the physiological signals. Data and algorithmic outcomes are first 
transferred to the MASS and the mIPP either obtains these with minimum latency 
if the system is operating in real-time mode or on a query-based approach where 
the expert specifies the time window to obtain data for. Fig. 10.22 shows an ex-
ample of the mIPP where the ECG analysis and the ARMEC analysis take place in 
the medical expert’s handheld device.  
 
           
(a)                                                                 (b) 
Fig. 50.22 – The interface of the mIPP application; (a) ECG analysis (b)   
ARMEC analysis 
 
 
10.8 Medical Analysis and Storage Subsystem (MASS) 
The MASS is in essence a server-type database that receives data, through an 
ftp link from the pIPP. In the normal mode of operation, data are stored locally on 
the MASS and upon a request from the mIPP, data that correspond to the specific 
timeframe, defined by the expert, are sent to the mIPP. In the real-time mode data 
are directly fused to the mIPP from the database with minimum latency. In addi-
tion to the mIPP, a web-based interface (Medical Expert Support Tool) was built 
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on the top of the MASS to provide doctor with an enhanced tool for the monitor-
ing of patients through the CHIRON system. In addition the MASS was built in 
such a way to facilitate the integration of multisource medical information and the 
analysis and feedbacks generation. Under CHIRON specialized software was de-
veloped to analyze and integrate all medical data obtained from heterogeneous 
sources (CHIRON sensor platform, imaging systems, laboratory values, epidemio-
logic data, lifestyle information, family history, etc.) and the data already existing 
in the Hospital System (HIS).  
 
In the core of the MASS, the Virtual Data Repository (VDR) (see Section 
10.8.1) provides an archetype-based solution to represent patients’ Electronic 
Health Records (EHR). As represented in components integration schema, VDR is 
commonly accessed by all the other component of the MASS. All the flow of in-
formation is done through the VDR accepting and delivering data in several stand-
ards. Fig. 10.23 illustrates the overall architecture of the MASS.  
 
 
Fig. 60.23 – CHIRON integration of multisource information 
 
The integration done during the CHIRON project has followed several steps: 
1. All the information is accessed using archetypes, but other standards are 
available (for instance HL7 CDA). 
2. Decision Support systems are communicated with the Advance or Slim 
Medical Expert Support Tool (MEST) Graphical User Interface. 
3. DSS communicates with the VDR directly. Once a day the three modules 
compute all the parameters stored in the database. 
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4. Retrieve the risk assessment values stored and the value of the parame-
ters. The DSS component gives the results and writes them in the VDR 
using the archetypes. 
5. An average of the parameters extracted from the raw data  information 
coming from the tele-monitoring (VDR Gathering service) should be 
stored once a session (three sessions a day) in order to provide to the doc-
tors a general view of the health status of the patient. 
The information inside the archetype is retrieved by means of a GUID (Global 
Unique Identifier) which permits to identify each object. For CHIRON project the 
communication is done using RESTful web services through JSON which is com-
patible with the MEST UI (Fielding 2000). The VDR is accessed using a proprie-
tary middleware (REST API). 
 
10.8.1 Virtual Data Repository (VDR) concept 
Heterogeneous medical information comes from multiple systems. The Virtual 
Data Repository is the middleware, which permits the connection with the data 
management transparently for the user. The VDR covers all the storage compo-
nents, the input to the modules of the system and will be the data on the patients, 
which will be gathered by the CHIRON sensor platform and contained in the pa-
tients' EHRs. However, data from other sources can also be included, for instance 
to train machine-learning classifiers and to demonstrate that the system works be-
fore the real data from CHF patients is available. The VDR is a set of repositories 
located somewhere and each element of the system could access to the data using 
the openEHR Kernel interface.  
The VDR is physically in the hospital and has some very bright and clear as-
pects:  
 It complies to the EU standard for medical data transport 
 It has an interface model that “talks” all standardised languages (XML, 
Edifact, etc.) 
 It can use the approved and authorized NHS Archetypes for this study 
 It can connect to other Interfaces (like the Southampton General Hospital 
or Sapienza University Hospital).  
10.8.2 Decision support system 
As mentioned previously, apart from the mIPP, with which the doctor is able to 
monitor the patient’s physiological data, a more elaborate tool is required to pro-
vide doctors with the information and analysis mechanisms needed to make clini-
cal decisions regarding the patient. Therefore a web-based decision support sys-
tem (DSS) was developed and linked to the VDR to accommodate this need.  
The risk assessment component is divided into three sub-components using 
three different approaches. The expert system sub-component incorporates exist-
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ing medical knowledge. The machine learning sub-component learns the relation 
between the parameters characterizing the patient’s health and his/her risk using 
an Artificial Neural Network. The anomaly detection sub-component detects 
anomalies in the values and relations between the values of the parameters charac-
terizing the patient’s health, using the Local Outlier Factor algorithm.” (Barca et. 
al. 2012). The literature search component is used when a doctor wishes to consult 
the medical literature on any issue that comes up during his/her decision-making 
process. It chiefly accesses data sources external to the CHIRON system, but the 
search can be contextualized by information from the patients’ EHRs. The priori-
tized parameters component attempts to identify the parameters important for the 
risk assessment, and interesting relations between them. It can thus provide sug-
gestions for the configuration of the risk assessment. 
10.8.3 VDR Bridge 
The openEHR REST API offers a set of functions to store and retrieve the data. 
In order to facilitate the access to the rest of components (DSS, MEST, etc.) a Java 
VDR library has been implemented called VDR Bridge. The library is a set of 
functions, which allow storing and retrieving the data from the openEHR REST 
API, but instead of using the long paths, the inputs and outputs are translated into 
meaningful clinical concepts. Fig. 10.24 shows a snapshot of the main functionali-
ties of the Java Library. 
 
 
Fig. 70.24 – VDR Bridge API doc. 
 
For the CHIRON Project several archetypes have been created or reused to 
cover 67 medical parameters in order to store the information in the VDR. The 
modified OBSERVATION archetypes have been used to retrieve the information 
(coming from the Monitoring Settings component). The CHIRON data is coming 
from the sensors and is retrieved using the archetypes included as entries inside 
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one composition of the patient EHR. For each parameter OBSERVATION and 
EVALUATION archetypes downloaded from the CKM (see chapters 6 and 8 for 
further details) or created ad-hoc have been used to show the measurements, dis-
eases, medications and so on.  
The way to configure the clinical concepts and the archetypes is using the 
openEHR configurator dragging and dropping the paths read from the archetypes. 
This tool allows the user associating the parameters needed by the doctors to the 
archetypes stored in the openEHR kernel. The Graphical User Interface read the 
configuration file and builds the screens dynamically. Fig. 10.25 shows an exam-
ple of concepts and archetypes. 
 
 
Fig. 10.25 – openEHR configurator. 
 
10.8.4 Medical Expert Support Tool (MEST) 
10.8.4.1 Advanced MEST 
“The Medical Expert Support Tools (MEST) is a set of UI-based tools built on 
top of Computer Based Clinical Decision Support System (CDSS). They have the 
purpose of helping the medical professionals to detect risk from chronic disease 
monitoring and subsequently to manage the risk in terms of assessment and inter-
vention to mitigate the dangerous situation related to the detected risk factor” 
(Barca et. al. 2012). 
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The Advanced MEST provides the medical professionals with a multi-
parametric view and an overall status of the patient indicating the risk factors with 
meaningful colours (green, yellow and red). The assessment of the person’s risk 
based on the analysis of the information already stored in the system offers the 
doctor a clear insight of the current situation of the individual. The detection of 
critical situations will activate the feedbacks to the patient and to the clinicians. 
The MEST API is designed and developed as a RESTful API to communicate be-
tween MEST applications and adapt data from CHIRON backend services and 
components exchanging the clinical data.  
The risk assessment procedure (Fig. 10.26Error! Reference source not 
found.) starts when the clinician configures the system communicating to the 
CDSS modules which parameters have to be measured and their corresponding 
thresholds. 
 
 
Fig. 10.26 – Monitoring Settings GUI 
 
Once the system is configured MEST presents the list of his/her patients with 
the overall risk coming from the CDSS components and stored in the VDR (see 
Fig. 10.27). The overall risk is calculated taking into account all the computed pa-
rameters shown by means of a green/yellow/red mark.  
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Fig. 10.27 – Overall risk assessment view. 
 
 
For each parameter configured an individual assessment is calculated (see Fig. 
10.28) to provide the doctors with the specific evaluation of the values producing 
the risk factor along with clinical literature articles related with the disease of the 
patient and his/her monitored clinical parameters (left down in Fig. 10.28). 
 
 
Fig. 10.28 – Individual risk assessment view and articles contextualised to this pa-
tient. 
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Finally the clinician can access the causes (parameter values) that led to the 
evaluation of a risk factor, displaying the complete history of the monitored clini-
cal parameters (see Fig. 10.29). The thresholds of the parameters are also shown in 
order to see if the values exceed the limits (above or below). 
 
 
Fig. 10.29 – Clinical data and thresholds view. 
 
10.8.4.2 Refinement of functional aspects for Observational 
Study: Slim MEST 
For the CHIRON Observational study the risk assessment modules were not in-
cluded due to the lack of relevant data, which will be gathered during this period. 
For this reason clinical partners defined a new set of requirements focused mainly 
on Observational Study requisites enabling the medical user to insert whatever 
clinical data associated to a patient in openEHR format. 
A new Graphical User Interface was proposed called “Slim MEST” which in-
cludes some parts of the MEST and allows the doctor to analyse the data of the pa-
tient (monitored data) collected in the overall observation period plus some data 
generated by the doctor himself. The risk assessment is not included since the 
“rules” are still to be defined.  
 
The Slim MEST includes: 
 Visualization of health status parameters 
It shows the last health status of the patient coming from the sensors. After a 
correct access, main screen is loaded. The visualization option offers an overview 
of parameters that have been measured for selected patient. A period of time can 
be pre-selected both general and individual for each of the parameters. Data is dis-
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played as a self-expandable table, which shows in every row parameter name be-
side its last value. Selecting one of the numeric parameters and choosing a period 
of time with different measurements produces a graph (Generate button) that illus-
trates parameter value variation. It is possible to generate a pdf file. 
 
 
Fig. 10.30 – Slim MEST: Visualization. 
 
 Insert parameters health status 
This option brings out a paginated list of all available parameters in CHIRON 
system. An empty text box lets the user update the value of each parameter. As a 
reference, last value stored is shown accompanied by the date when the measure-
ment was taken. In case the user wants to repeat the value, a copy button provides 
this functionality. It will update the value with the current day and time. Controls 
section in the bottom of the page, lets the user: 
 
 Move back and forward between pages. 
 Print a PDF report with inserted values. 
 Store values. 
 Exit the insertion module. 
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Fig. 10.31 – Last Health Status reports generation 
 
Security Aspects 
MEST has been designed to be embedded in a security system. From the point 
of view of the Graphical User Interface the main aspects to be considered are the 
authorization and authentication aspects. An authorization mechanism that allows 
the identification and access levelling of a caregiver is highly recommended, both 
for security purposes and for privacy concerns. The REST services are designed to 
expect that the UIs add a textual (String) representation of an authorization token 
to every privacy-concerned (or potentially risky) action the user wishes to perform 
(e.g. request of the clinical data of a patient, or the notification of a risk ac-
ceptance). Slim MEST requires a Google account to get access to the tool (due to 
authentication process). Users that own a Google account can write their access 
details. The rest, can Sign up for a new account. After entering the system, the ap-
plication asks for permission to access through your Google account. Accessing 
through Google API produces a token, which is required by VDR API which con-
tains a list of medical users and patients associated to provide authorization. 
 
 
10.9 Conclusions 
This chapter provided the reader with analytical details of the CHIRON Pro-
ject case study. The CHIRON Project  focused  on  combining  state-of-the  art  
technologies  and  innovative solutions  into  an  integrated  framework  designed  
for  an  effective  and  person-centric  health management along the complete care 
cycle of CVD. Within the areas of e-health and tele-medicine, the CHIRON case 
study proposed a holistic system architecture constituting of a wearable sensor 
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system, its corresponding mobile application and an advanced interface for medi-
cal evaluation and analysis bundled into a single integrated framework for the con-
tinuous evaluation and assessment of CVD patients. To the best of the author’s 
knowledge the CHIRON system is the very first attempt of an e-health tele-
monitoring system towards the Proactive Approach for the care of CVD. The 
CHIRON system is envisioned as a tool to provide medical experts with the de-
sired technological support for analyzing the variation and the correlation of het-
erogeneous medical data in an attempt to introduce novel biomarkers for the 
preemptive intervention in CVD.  
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